NCT07554521
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07554521
Title A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors BeOne Medicines
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Los Angeles Cancer Network RECRUITING Los Angeles California 90017-4803 United States Details
Bioresearch Partners Holding Hialeah Hospital RECRUITING Hialeah Florida 33013-3804 United States Details
Florida Clinical Trials Group Plantation RECRUITING Plantation Florida 33322 United States Details
Florida Clinical Trials Group Tamarac RECRUITING Tamarac Florida 33321 United States Details
Washington University School of Medicine RECRUITING St Louis Missouri 63110-1010 United States Details
Gabrail Cancer Center Research RECRUITING Canton Ohio 44718-2566 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field